NeuroPace's chart data is dated 2026-10-09. There is no active technical signal. There are 0 published signal records.
NeuroPace last closed at $12.67 (+2.26%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -22.6×. Its overall grade ranks 472 of 736 stocks in Healthcare.
About this company
NeuroPace last closed at $12.67 (+2.26%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 472/736
Valuation grade A
Related stocks
- MedtronicCompetitor
뇌심부자극기·신경조절 등 신경기기 분야의 대형 경쟁사
- AbbottCompetitor
신경자극·의료기기 포트폴리오를 가진 경쟁사
- Boston ScientificCompetitor
신경조절·의료기기 시장에서 경쟁하는 대형 업체
About NeuroPace
- What technical signals does NeuroPace (NPCE) have?
- NeuroPace current technical signals: no active technical signal.
- Is NeuroPace a cup-and-handle pattern?
- No. NeuroPace has no valid Cup signal right now.
- What published figures are available for NeuroPace?
- Market cap: $419.14M. Trailing 12 months PER: -22.6×. Latest quarter PBR: 36.36×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-10 dataset
Turn what you saw on this name into a strategy
Ask Q about NeuroPace, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.